HLN:NYSE
Haleon PLC - ADR
$9.17
arrow_upward
+0.94%(+0.085) 1D
$9.17
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 13, 4:00:02 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HLN...
Open
$9.13
High
$9.22
Low
$9.11
Mkt. cap
40.13B
Avg. vol.
20.92M
Volume
16.11M
Dividend
2.16%
Quarterly dividend
$0.05
Ex-dividend date
Aug 13, 2026
P/E ratio
19.13
52-wk high
$11.28
52-wk low
$8.38
EPS
$0.48
Beta
0.17
Shares outstanding
4.39B
No. of employees
25K
Open
$9.13
High
$9.22
Low
$9.11
Mkt. cap
40.13B
Avg. vol.
20.92M
Volume
16.11M
Dividend
2.16%
Quarterly dividend
$0.05
Ex-dividend date
Aug 13, 2026
P/E ratio
19.13
52-wk high
$11.28
52-wk low
$8.38
EPS
$0.48
Beta
0.17
Shares outstanding
4.39B
No. of employees
25K
News stories
From web sources and news partners
TradingView
·
1 hour ago
EXCLUSIVE: S&P 500’s Sell-Off Tested Buffered ETFs: Expert Explains Why a 10% Buffer May Not Protect You as Expected
Nasdaq
·
23 hours ago
Chartstopper: November 13, 2026
Benzinga
·
22 minutes ago
VOO & Chill: Inflows Stay Strong as Risk-Off Sentiment Pressures the S&P 500
Profile
Haleon plc is a British multinational consumer healthcare company with headquarters in Weybridge, England. It is one of the largest consumer healthcare businesses in the world, with brands including Sensodyne toothpaste, Panadol and Advil painkillers, and Centrum vitamins. The company was projected to be a global leader in over the counter medicines with a 7.3 per cent market share in 2022.
Haleon was established on 18 July 2022 as a corporate spin-off from GSK. Haleon is listed on the London Stock Exchange and is a component of the FTSE 100, with a secondary listing on the New York Stock Exchange. Wikipedia
About Haleon PLC - ADR
CEO-
Employees24.5K
FoundedJul 18, 2022
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitehaleon.com